Seok Jin Kim

14.1k total citations · 1 hit paper
437 papers, 8.1k citations indexed

About

Seok Jin Kim is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Seok Jin Kim has authored 437 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 251 papers in Pathology and Forensic Medicine, 197 papers in Oncology and 83 papers in Molecular Biology. Recurrent topics in Seok Jin Kim's work include Lymphoma Diagnosis and Treatment (246 papers), Viral-associated cancers and disorders (96 papers) and CNS Lymphoma Diagnosis and Treatment (65 papers). Seok Jin Kim is often cited by papers focused on Lymphoma Diagnosis and Treatment (246 papers), Viral-associated cancers and disorders (96 papers) and CNS Lymphoma Diagnosis and Treatment (65 papers). Seok Jin Kim collaborates with scholars based in South Korea, United States and Japan. Seok Jin Kim's co-authors include Won Seog Kim, Young Hyeh Ko, Kihyun Kım, Cheolwon Suh, Sang Eun Yoon, Yok‐Lam Kwong, Jin Seok Kim, Eric Tse, Soon Thye Lim and Chul Won Choi and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Seok Jin Kim

416 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

2017 359 citations Seok Jin Kim et al. Blood profile →

Peers

Countries citing papers authored by Seok Jin Kim

Since Specialization

Citations

This map shows the geographic impact of Seok Jin Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seok Jin Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seok Jin Kim more than expected).

Fields of papers citing papers by Seok Jin Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seok Jin Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seok Jin Kim. The network helps show where Seok Jin Kim may publish in the future.

Co-authorship network of co-authors of Seok Jin Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Seok Jin Kim. A scholar is included among the top collaborators of Seok Jin Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seok Jin Kim. Seok Jin Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Endoscopic Features of Gastrointestinal Amyloidosis: A Proposed Endoscopic Classification 2025 ·Gut and Liver ·(unknown), (unknown), (unknown), Eun Ran Kim, Ga Yeon Lee, Sang Eun Yoon, Seok Jin Kim, Jung‐Sun Kim, Dong Kyung Chang, Young‐Ho Kim, Eun-Seok Jeon, Kihyun Kım, Sung Noh Hong	0
2	Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma 2024 ·Cancer Research and Treatment ·Sang Eun Yoon, Seung‐Ho Shin, (unknown), Junhun Cho, Won Seog Kim, Seok Jin Kim	6
3	Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma 2024 ·Experimental Cell Research ·(unknown), (unknown), Kyung Ju Ryu, Chaehwa Park, (unknown), Sang Eun Yoon, (unknown), (unknown), Jung Yong Hong, Seok Jin Kim	2
4	Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea 2023 ·Cancer Research and Treatment ·Ji Yun Lee, Ji Hyun Kwon, Joon Young Hur, Jun Ho Yi, Ji‐Hyun Lee, Hyungwoo Cho, Young Rok, Jae‐Cheol Jo, Hye Jin Kang, (unknown), Won Sik Lee, (unknown), Sang Eun Yoon, Seok Jin Kim, Jeong‐Ok Lee	4
5	Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis 2023 ·BMC Medical Imaging ·Yong‐Jin Park, (unknown), Darae Kim, Jin‐Oh Choi, Seok Jin Kim, Kihyun Kım, Joon Young Choi	0
6	Single Center Experience of Autologous Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis in Korea 2022 ·Clinical Lymphoma Myeloma & Leukemia ·Hye Ryeon Kim, Sang Eun Yoon, Darae Kim, Jin‐Oh Choi, Ju‐Hong Min, Byung Jun Kim, Jung‐Sun Kim, Jung Eun Lee, Joon Young Choi, Eun‐Seok Jeon, Seok Jin Kim, Kihyun Kım	1
7	Generalised autonomic failure as a prognostic factor in systemic light-chain (AL) amyloidosis 2022 ·Amyloid ·Soonwook Kwon, (unknown), (unknown), (unknown), Eun Bin Cho, Jin Myoung Seok, Seok Jin Kim, Kihyun Kım, Eun‐Seok Jeon, Ju‐Hong Min, Byoung Joon Kim	2
8	Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma 2022 ·Annals of Laboratory Medicine ·Hyun‐Young Kim, In Young Yoo, (unknown), Hee‐Jin Kim, Sun‐Hee Kim, Sang Eun Yoon, Seok Jin Kim, Duck Cho, Kihyun Kım	6
9	Comprehensive Understanding of Gut Microbiota in Treatment Naïve Diffuse Large B Cell Lymphoma Patients 2021 ·Blood ·Sang Eun Yoon, Woorim Kang, Mauricio Chalita, Jeong-Min Lim, Won Seog Kim, Seok Jin Kim	5
10	Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34⁺ cell counts differs according to diagnosis in patients undergoing autologous peripheral blood stem cell transplantation 2021 ·Journal of Clinical Apheresis ·Sangmi Kim, Hyun‐Young Kim, Seok Jin Kim, Jun Ho Jang, Kihyun Kım, Won Seog Kim, Chul Won Jung, Duck Cho, Eun‐Suk Kang	4
11	Prevalence and Immunophenotypic Characteristics of Monoclonal B-Cell Lymphocytosis in Healthy Korean Individuals With Lymphocytosis 2020 ·Annals of Laboratory Medicine ·In Young Yoo, (unknown), (unknown), Seok Jin Kim, Kyunga Kim, Hee‐Jin Kim, Sun‐Hee Kim, Duck Cho	1
12	Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma 2020 ·Bone Marrow Transplantation ·Ga‐Young Song, Dok Hyun Yoon, Cheolwon Suh, Joon Ho Moon, Dong Won Baek, Jin Seok Kim, Gyeong‐Won Lee, Jun Ho Yi, Yong Park, Ki Sun Jung, Seok Jin Kim, Deok‐Hwan Yang, Won Seog Kim	10
13	Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma 2020 ·Blood ·(unknown), Hyehyun Jeong, Motoko Yamaguchi, Insuk Sohn, Sang Eun Yoon, Seonggyu Byeon, Joon Young Hur, Youngil Koh, Sung‐Soo Yoon, (unknown), Masahiko Oguchi, Kana Miyazaki, (unknown), Dok Hyun Yoon, Junhun Cho, Young Hyeh Ko, Seok Jin Kim, Ritsuro Suzuki, Won Seog Kim	17
14	Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion 2019 ·Clinical Cancer Research ·Daeun Ryu, Seok Jin Kim, Yourae Hong, Areum Jo, Nayoung Kim, Hee‐Jin Kim, Hae‐Ock Lee, Kihyun Kım, Woong‐Yang Park	54
15	Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma 2019 ·BMC Cancer ·Seok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, Jung Yong Hong, Ho Sup Lee, Sung Yong Oh, Ho‐Jin Shin, Jee Hyun Kong, Jun Ho Yi, Kana Sakamoto, Young Hyeh Ko, Jooryung Huh, Seung‐Sook Lee, Kengo Takeuchi, Dong‐Yeop Shin, Cheolwon Suh, Won Seog Kim	20
16	Flow Cytometric Analysis of T Cells in Hemophagocytic Lymphohistiocytosis 2019 ·Annals of Laboratory Medicine ·(unknown), In Young Yoo, Hee‐Jin Kim, Sun‐Hee Kim, Seok Jin Kim, Duck Cho	8
17	Isolation of Small Extracellular Vesicles From Human Serum Using a Combination of Ultracentrifugation With Polymer-Based Precipitation 2019 ·Annals of Laboratory Medicine ·Kyung Ju Ryu, (unknown), Chaehwa Park, Duck Cho, Seok Jin Kim	54
18	Routine Prophylaxis of Pneumocystis Pneumonia from the Fourth Cycle of R-CHOP Regimen in DLBCL Patients 2017 ·Blood ·Silvia Park, Seok Jin Kim, Won Seog Kim	0
19	Rituximab Plus CHOP for the Treatment of Primary Mediastinal Large B Cell Lymphoma in a Pregnant Woman 2011 ·The Korean Journal of Internal Medicine ·Eun Kyoung Kim, Seok Jin Kim, Sung Bum Park, (unknown), Young Hye Ko, Won Seog Kim	2
20	¹⁸ F‐FDG uptake and its clinical relevance in primary gastric lymphoma 2009 ·Hematological Oncology ·(unknown), Seok Jin Kim, Joon Young Choi, Young Hyeh Ko, Byung‐Tae Kim, Won Seog Kim	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact